Skip to main content
Top

Cellular Oncology

Issue 6/2022

Content (25 Articles)

Molecular actions of exosomes and their theragnostics in colorectal cancer: current findings and limitations

Wen-Chun Lin, Chun-Chi Lin, Yen-Yu Lin, Wen-Hao Yang, Yuh-Ching Twu, Hao-Wei Teng, Wei-Lun Hwang

Applications and mechanisms of the cyclin-dependent kinase 4/6 inhibitor, PD-0332991, in solid tumors

Wenjian Chen, Wencheng Zhang, Miaomiao Chen, Chao Yang, Ting Fang, Haifeng Wang, Lola M. Reid, Zhiying He

Molecular mechanisms underlying the action of carcinogens in gastric cancer with a glimpse into targeted therapy

Elham Patrad, Solmaz Khalighfard, Taghi Amiriani, Vahid Khori, Ali Mohammad Alizadeh

Glioma Review

Role of nerves in neurofibromatosis type 1-related nervous system tumors

Ling-Ling Ge, Ming-Yan Xing, Hai-Bing Zhang, Qing-Feng Li, Zhi-Chao Wang

Colorectal Cancer Original Article

Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution

Guanglong Chen, Ting Gong, Zhe Wang, Zeyu Wang, Xiaolin Lin, Sunrui Chen, Chu Sun, Weijie Zhao, Ye Kong, Huihan Ai, Hang Yang, Yusheng Liu, Fangyan Wu, Jiawei Kang, Shasha Zhao, Xiuying Xiao, Jing Sun, Aina He, Zhi Li

Correction to: Colorectal cancer organoid models uncover oxaliplatin-resistant mechanisms at single cell resolution

Guanglong Chen, Ting Gong, Zhe Wang, Zeyu Wang, Xiaolin Lin, Sunrui Chen, Chu Sun, Weijie Zhao, Ye Kong, Huihan Ai, Hang Yang, Yusheng Liu, Fangyan Wu, Jiawei Kang, Shasha Zhao, Xiuying Xiao, Jing Sun, Aina He, Zhi Li

Open Access Endometrial Cancer Original Article

Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells

Thomas Kolben, Mareike Mannewitz, Carolin Perleberg, Konstantin Schnell, David Anz, Laura Hahn, Sarah Meister, Elisa Schmoeckel, Alexander Burges, Bastian Czogalla, Anna Hester, Sven Mahner, Mirjana Kessler, Udo Jeschke, Stefanie Corradini, Fabian Trillsch, Susanne Beyer

DNASE1L3 inhibits hepatocellular carcinoma by delaying cell cycle progression through CDK2

Jiaqi Sun, Xiyang Wang, Qingsong Shen, Min Wang, Shuxian Chen, Xuechun Zhang, Yongping Huang, Zhonglin Zhang, Wenhua Li, Yufeng Yuan, Zan Huang

Cytostatic Therapy Original Article

Inhibition of PP2A by LB100 sensitizes bladder cancer cells to chemotherapy by inducing p21 degradation

Song Gao, Liping Shan, Mo Zhang, Yan Wang, Xi Zhan, Yalei Yin, Zhonghao Jiang, Xinyi Tao, Xinyu Li, Mingliang Ye, Yang Liu

Original Article

CEP55 3’-UTR promotes epithelial–mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p

Chenglin Yang, Yue Yang, Wei Wang, Wuer Zhou, Xiaoming Zhang, Yuansong Xiao, Huifen Zhang

Open Access Statins Original Article

ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis

Michela Pasello, Anna Maria Giudice, Camilla Cristalli, Maria Cristina Manara, Caterina Mancarella, Alessandro Parra, Massimo Serra, Giovanna Magagnoli, Florencia Cidre-Aranaz, Thomas G. P. Grünewald, Carla Bini, Pier-Luigi Lollini, Alessandra Longhi, Davide Maria Donati, Katia Scotlandi

Open Access Sarcoma Correction

Correction to: ABCA6 affects the malignancy of Ewing sarcoma cells via cholesterol-guided inhibition of the IGF1R/AKT/MDM2 axis

Michela Pasello, Anna Maria Giudice, Camilla Cristalli, Maria Cristina Manara, Caterina Mancarella, Alessandro Parra, Massimo Serra, Giovanna Magagnoli, Florencia Cidre-Aranaz, Thomas G. P. Grünewald, Carla Bini, Pier-Luigi Lollini, Alessandra Longhi, Davide Maria Donati, Katia Scotlandi

Metastasis Original Article

OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis

Mengling Wu, Qianrui Huang, Mengya Liao, Xuyi Wu, Huizhi Xi, Hongbo Ma, Shanrui Li, Yiwen Zhang, Yong Xia

Soft Tissue Sarcoma Original Article

Comparative oncology reveals DNMT3B as a molecular vulnerability in undifferentiated pleomorphic sarcoma

Ashley M. Fuller, Ann DeVine, Ileana Murazzi, Nicola J. Mason, Kristy Weber, T. S. Karin Eisinger-Mathason

Open Access Original Article

Low-dose anti-VEGFR2 therapy promotes anti-tumor immunity in lung adenocarcinoma by down-regulating the expression of layilin on tumor-infiltrating CD8+T cells

Biaolong Yang, Biaolong Deng, Xiao-Dong Jiao, Bao-Dong Qin, Yi Lu, Weiqi Zhang, Yixian Guo, Shiqi Chen, Dan Li, Bin Li, Yuan-Sheng Zang

Open Access Prostate Cancer Original Article

Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogramming

Yunjian Wu, Kimberley C. Clark, Elizabeth V. Nguyen, Birunthi Niranjan, Lisa G. Horvath, Renea A. Taylor, Roger J. Daly

Interferon Original Article

Blockade of USP14 potentiates type I interferon signaling and radiation-induced antitumor immunity via preventing IRF3 deubiquitination

Weijian Wu, Huiying Xu, Chenyang Liao, Youqiao Wang, Ruirui Wu, Jiaxin Wu, Wenlv Zheng, Yunzhi Li, Chaoying Jin, Yuxuan Zhao, Junmin Quan, Xin Yue, Xianzhang Bu

Rectal Cancer Original Article

Distinct tumor microenvironment landscapes of rectal cancer for prognosis and prediction of immunotherapy response

Fanqin Bu, Yu Zhao, Yushan Zhao, Xiaohan Yang, Lan Sun, Yang Chen, Shengtao Zhu, Li Min

Original Article

FSCN1 induced PTPRF-dependent tumor microenvironment inflammatory reprogramming promotes lung adenocarcinoma progression via regulating macrophagic glycolysis

Yiwei Huang, Guangyao Shan, Yanjun Yi, Jiaqi Liang, Zhengyang Hu, Guoshu Bi, Zhencong Chen, Junjie Xi, Di Ge, Qun Wang, Lijie Tan, Wei Jiang, Cheng Zhan

Open Access Targeted Therapy Original Article

Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy

Fabrice Viol, Bence Sipos, Martina Fahl, Till S. Clauditz, Tania Amin, Malte Kriegs, Maike Nieser, Jakob R. Izbicki, Samuel Huber, Ansgar W. Lohse, Jörg Schrader

Pancreatic Cancer Original Article

ITGA2 induces STING expression in pancreatic cancer by inducing DNMT1 degradation

Junpeng Meng, Hongkun Cai, Yan Sun, Shuang Wen, Heshui Wu, Dianyun Ren

Open Access Hepatocellular Carcinoma Original Article

The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth

Gao Liu, Zhang-Fu Yang, Jian Sun, Bao-Ye Sun, Pei-Yun Zhou, Cheng Zhou, Ruo-Yu Guan, Zhu-Tao Wang, Yong Yi, Shuang-Jian Qiu

Glioblastoma Original Article

Distinct expression and function of breast cancer metastasis suppressor 1 in mutant P53 glioblastoma

Deepak Babu, Ramulu Chintal, Manas Panigrahi, Prakash Babu Phanithi

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine